207 related articles for article (PubMed ID: 1560164)
1. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours.
Derom EY; Pauwels RA; Van der Straeten ME
J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164
[TBL] [Abstract][Full Text] [Related]
2. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
4. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
Simons FE; Soni NR; Watson WT; Becker AB
J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
[TBL] [Abstract][Full Text] [Related]
5. Dose equivalence and bronchoprotective effects of salmeterol and salbutamol in asthma.
Higham MA; Sharara AM; Wilson P; Jenkins RJ; Glendenning GA; Ind PW
Thorax; 1997 Nov; 52(11):975-80. PubMed ID: 9487346
[TBL] [Abstract][Full Text] [Related]
6. Rapid onset of tolerance to the bronchoprotective effect of salmeterol.
Bhagat R; Kalra S; Swystun VA; Cockcroft DW
Chest; 1995 Nov; 108(5):1235-9. PubMed ID: 7587422
[TBL] [Abstract][Full Text] [Related]
7. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
8. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children.
Verberne AA; Hop WC; Bos AB; Kerrebijn KF
J Allergy Clin Immunol; 1993 Jan; 91(1 Pt 1):127-34. PubMed ID: 8093705
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
10. Sustained protection against distilled water provocation by a single dose of salmeterol in patients with asthma.
Bootsma GP; Dekhuijzen PN; Festen J; Lammers JW; Mulder PG; van Herwaarden CL
Eur Respir J; 1997 Oct; 10(10):2230-6. PubMed ID: 9387945
[TBL] [Abstract][Full Text] [Related]
11. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.
Boulet LP; Turcotte H; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
Chest; 1998 Aug; 114(2):373-9. PubMed ID: 9726717
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids.
Boulet LP; Cartier A; Milot J; Côté J; Malo JL; Laviolette M
Eur Respir J; 1998 May; 11(5):1091-7. PubMed ID: 9648961
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
14. A Dose-Response Study Examining the Use of Methacholine Challenge to Demonstrate Local Therapeutic Equivalence of the Salmeterol Component of Generic Inhaled Fluticasone Propionate/Salmeterol Combination Products.
Allan R; Haughie S; Ahrens R; Singh S; Ward J
J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):352-363. PubMed ID: 31259673
[No Abstract] [Full Text] [Related]
15. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.
Wong AG; O'Shaughnessy AD; Walker CM; Sears MR
Eur Respir J; 1997 Feb; 10(2):330-6. PubMed ID: 9042628
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours.
Nowak D; Jörres R; Rabe KF; Lüthke M; Wiessmann J; Magnussen H
Eur J Clin Pharmacol; 1992; 43(6):591-5. PubMed ID: 1493839
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
Drotar DE; Davis EE; Cockcroft DW
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
